CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-25 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −5,418 | $74.00 | $401K | 110,994 |
| 2025-11-25 | Anders Jack Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,418 | 0 | ||
| 2025-11-25 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +60,000 | $4.09 | $245K | 307,863 |
| 2025-11-25 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −60,000 | $75.08 | $4.5M | 247,863 |
| 2025-11-25 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −3,000 | $75.00 | $225K | 67,424 |
| 2025-11-25 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −3,000 | $75.00 | $225K | 67,424 |
| 2025-11-25 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −60,000 | 77,708 | ||
| 2025-11-18 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +20,000 | $4.09 | $82K | 267,863 |
| 2025-11-18 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −20,000 | $70.38 | $1.4M | 247,863 |
| 2025-11-18 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 137,708 | ||
| 2025-11-18 | Cislini Jeff General Counsel | Option exercise 10b5-1 | +13,388 | $42.45 | $568K | 63,813 |
| 2025-11-18 | Cislini Jeff General Counsel | Sale 10b5-1 | −13,388 | $70.14 | $939K | 50,425 |
| 2025-11-18 | Cislini Jeff General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,388 | 0 | ||
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +20,000 | $4.09 | $82K | 267,863 |
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −20,000 | $65.07 | $1.3M | 247,863 |
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 157,708 | ||
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Gift 10b5-1 | −50,000 | 297,863 | ||
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Gift 10b5-1 | −50,000 | 247,863 | ||
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Gift 10b5-1 | +50,000 | 70,424 | ||
| 2025-11-12 | GOLDSMITH MARK A See Remarks | Gift 10b5-1 | +50,000 | 54,498 |
Page 14 of 18 · 352 trades